{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:14:31Z","timestamp":1790702071071,"version":"4.1.0"},"reference-count":36,"publisher":"The Endocrine Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Androgen excess in women with polycystic ovary syndrome (PCOS) may be ovarian and\/or adrenal in origin, and one proposed contributing mechanism is altered cortisol metabolism. Increased peripheral metabolism of cortisol may occur by enhanced inactivation of cortisol by 5\u03b1-reductase (5\u03b1-R) or impaired reactivation of cortisol from cortisone by 11\u03b2-hydroxysteroid dehydrogenase type 1 (11\u03b2-HSD1) resulting in decreased negative feedback suppression of ACTH secretion maintaining normal plasma cortisol concentrations at the expense of androgen excess. We have tested whether any enzyme dysregulation was related to circulating insulin or androgen concentrations in women with PCOS and have sought to clarify their relationship with obesity.<\/jats:p>\n               <jats:p>First, to avoid obesity-related effects on cortisol metabolism, 18 lean women with PCOS were compared with 19 lean controls who were closely matched for body mass index (BMI). Second, the impact of obesity was studied in a cross-section of 42 PCOS women of a broad range of BMI. We measured 24-h urinary excretion of steroid metabolites by gas chromatography\/mass spectrometry and fasting metabolic and hormone profiles.<\/jats:p>\n               <jats:p>Urinary excretion of androgens [androsterone (P = 0.003), etiocholanolone (P = 0.02), and C19 steroid sulfates (P = 0.009)], cortisone metabolites [tetrahydrocortisone (THE) (P = 0.02), \u03b1-cortolone (P &amp;lt; 0.001), \u03b2-cortol + \u03b2-cortolone (P &amp;lt; 0.001), cortolones (P &amp;lt; 0.001), and E metabolites (P &amp;lt; 0.001)], and TCM (P = 0.002) were raised in lean PCOS subjects when compared with controls. A significantly higher 5\u03b1-tetrahydrocortisol (5\u03b1-THF)\/5\u03b2-THF ratio (P = 0.04) and a significantly lower \u03b1-THF + THF + \u03b1-cortol\/THE + cortolones ratio (P = 0.01) were found in lean PCOS women compared with lean controls, indicating both enhanced 5\u03b1-R and reduced 11\u03b2-HSD1 activities. A decreased THE\/cortolones ratio (P = 0.03) was also found in lean PCOS women compared with lean controls, indicating increased 20 \u03b1\/\u03b2-HSD activity.<\/jats:p>\n               <jats:p>In the group of 42 PCOS subjects, measures of 5\u03b1\/5\u03b2 reduction were positively correlated with the homeostasis model insulin resistance index (HOMA-R): \u03b1-THF\/THF and HOMA-R (r = 0.34; P = 0.03), androsterone\/etiocholanolone and HOMA-R (r = 0.32; P = 0.04), and total 5\u03b1 \/total 5\u03b2 and HOMA-R (r = 0.37; P = 0.02). A positive correlation was also found between measures of 5\u03b1-R and BMI (r = 0.37; P = 0.02). No correlation was found between measures of 11\u03b2-HSD1 activity and indices of insulin sensitivity or BMI.<\/jats:p>\n               <jats:p>We have demonstrated that there is an increased production rate of cortisol and androgens as measured in vivo in lean PCOS women. Insulin seems to enhance 5\u03b1 reduction of steroids in PCOS but was not associated with the elevated cortisol production rate. The changes in 5\u03b1-R, 11\u03b2-HSD1, and 20\u03b1\/\u03b2-HSD enzyme activities observed in PCOS may contribute to the increased production rates of cortisol and androgens, supporting the concept of a widespread dysregulation of steroid metabolism. This dysregulation does not seem to be the primary cause of PCOS because no correlation was found between serum androgen levels or urinary excretion of androgens with measurements of either 5\u03b1-R or 11\u03b2-HSD1 activities.<\/jats:p>","DOI":"10.1210\/jc.2003-030240","type":"journal-article","created":{"date-parts":[[2003,12,11]],"date-time":"2003-12-11T22:23:51Z","timestamp":1071181431000},"page":"5907-5913","source":"Crossref","is-referenced-by-count":123,"title":["Altered Cortisol Metabolism in Polycystic Ovary Syndrome: Insulin Enhances 5\u03b1-Reduction But Not the Elevated Adrenal Steroid Production Rates"],"prefix":"10.1210","volume":"88","author":[{"given":"Tasoula","family":"Tsilchorozidou","sequence":"first","affiliation":[{"name":"Departments of Endocrinology and Chemical Biochemistry, University College London Hospitals, London W1T 3AA, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Honour","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology and Chemical Biochemistry, University College London Hospitals, London W1T 3AA, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard S.","family":"Conway","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology and Chemical Biochemistry, University College London Hospitals, London W1T 3AA, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071614081458200_R1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev.bi.63.070194.000325","article-title":"Steroid 5\u03b1-reductase: two genes\/two enzymes.","volume":"63","author":"Russell","year":"1994","journal-title":"Annu Rev Biochem"},{"key":"2020071614081458200_R2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0140-6736(90)90664-Q","article-title":"5\u03b1-Reductase activity in polycystic ovary syndrome.","volume":"335","author":"Stewart","year":"1990","journal-title":"Lancet"},{"key":"2020071614081458200_R3","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1210\/jcem-56-2-320","article-title":"Dihydrotestosterone stimulates 5\u03b1-reductase activity in pubic skin fibroblasts.","volume":"56","author":"Mowszowicz","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614081458200_R4","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1210\/endo.133.2.8344190","article-title":"Androgen induction of steroid 5\u03b1-reductase may be mediated via insulin-like growth factor-I.","volume":"133","author":"Horton","year":"1993","journal-title":"Endocrinology"},{"key":"2020071614081458200_R5","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1210\/jc.2002-021875","article-title":"Beyond adrenal and ovarian androgen generation: increased peripheral 5\u03b1-reductase activity in women with polycystic ovary syndrome.","volume":"88","author":"Fassnacht","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614081458200_R6","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1056\/NEJM199402173300703","article-title":"Hyperandrogenism in polycystic ovary syndrome. Evidence of dysregulation of 11\u03b2-hydroxysteroid dehydrogenase.","volume":"330","author":"Rodin","year":"1994","journal-title":"N Engl J Med"},{"key":"2020071614081458200_R7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1365-2265.1999.00598.x","article-title":"An in vivo study of the cortisol-cortisone shuttle in subcutaneous abdominal adipose tissue.","volume":"50","author":"Katz","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614081458200_R8","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1210\/jcem.86.3.7453","article-title":"Tissue-specific dysregulation of cortisol metabolism in human obesity.","volume":"86","author":"Rask","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614081458200_R9","first-page":"3330","article-title":"Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11\u03b2-hydroxysteroid dehydrogenase type 1 activity.","volume":"87","author":"Rask","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614081458200_R10","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1210\/endo.142.4.8114","article-title":"Minireview: 11\u03b2-hydroxysteroid dehydrogenase type 1, a tissue-specific amplifier of glucocorticoid action.","volume":"142","author":"Seckl","year":"2001","journal-title":"Endocrinology"},{"key":"2020071614081458200_R11","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1677\/joe.0.1430541","article-title":"Sexual dimorphism of hepatic 11\u03b2-hydroxysteroid dehydrogenase in the rat: the role of growth hormone patterns.","volume":"143","author":"Low","year":"1994","journal-title":"J Endocrinol"},{"key":"2020071614081458200_R12","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-2265.1994.tb01830.x","article-title":"The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults.","volume":"41","author":"Weaver","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614081458200_R13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1365-2265.1998.00575.x","article-title":"Growth hormone replacement inhibits renal and hepatic 11\u03b2-hydroxysteroid dehydrogenases in ACTH-deficient patients.","volume":"49","author":"Walker","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614081458200_R14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1365-2265.1998.3641180.x","article-title":"The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11\u03b2-hydroxysteroid dehydrogenase activity.","volume":"48","author":"Gelding","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614081458200_R15","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1210\/jcem-73-2-326","article-title":"Regulation of 11\u03b2-hydroxysteroid dehydrogenase activity in human skin fibroblasts: enzymatic modulation of glucocorticoid action.","volume":"73","author":"Hammami","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614081458200_R16","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1210\/endo.136.11.7588203","article-title":"11\u03b2-Hydroxysteroid dehydrogenase is an exclusive 11\u03b2-reductase in primary cultures of rat hepatocytes: effect of physicochemical and hormonal manipulations.","volume":"136","author":"Jamieson","year":"1995","journal-title":"Endocrinology"},{"key":"2020071614081458200_R17","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/S0140-6736(96)11222-8","article-title":"Does central obesity reflect \u201cCushing\u2019s disease of the omentum\u201d?","volume":"349","author":"Bujalska","year":"1997","journal-title":"Lancet"},{"key":"2020071614081458200_R18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1365-2265.1998.00494.x","article-title":"Sexual dimorphism in 11\u03b2-hydroxysteroid dehydrogenase activity and its relation to fat distribution and insulin sensitivity: a study in hypopituitary subjects.","volume":"49","author":"Weaver","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614081458200_R19","first-page":"1022","article-title":"Cortisol metabolism in human obesity: impaired cortisone\u2192cortisol conversion in subjects with central adiposity.","volume":"84","author":"Stewart","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614081458200_R20","first-page":"3316","article-title":"Cortisol metabolism in healthy young adults: sexual dimorphism in activities of A-ring reductases, but not 11\u03b2-hydroxysteroid dehydrogenases.","volume":"84","author":"Finken","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614081458200_R21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2265.2000.00893.x","article-title":"Endogenous inhibitors of 11\u03b2-hydroxysteroid dehydrogenase type 1 do not explain abnormal cortisol metabolism in polycystic ovary syndrome.","volume":"52","author":"Walker","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614081458200_R22","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1210\/jcem.83.5.4951","article-title":"Obesity and gender influence cortisol secretion and metabolism in man.","volume":"83","author":"Andrew","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614081458200_R23","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1210\/jcem-57-2-356","article-title":"Insulin resistance in nonobese patients with polycystic ovarian disease.","volume":"57","author":"Chang","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614081458200_R24","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome.","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"2020071614081458200_R25","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2337\/diab.41.10.1257","article-title":"Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome.","volume":"41","author":"Dunaif","year":"1992","journal-title":"Diabetes"},{"key":"2020071614081458200_R26","first-page":"2854","article-title":"Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.","volume":"81","author":"Morales","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614081458200_R27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/000456329703400106","article-title":"Steroid profiling.","volume":"34","author":"Honour","year":"1997","journal-title":"Ann Clin Biochem"},{"key":"2020071614081458200_R28","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/clinchem\/30.9.1579a","article-title":"Urinary steroid measurements in hirsute women.","volume":"30","author":"Phillipou","year":"1984","journal-title":"Clin Chem"},{"key":"2020071614081458200_R29","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0300-595X(86)80027-5","article-title":"Regulation of androgen receptor and 5\u03b1-reductase in the skin of normal and hirsute women.","volume":"15","author":"Mauvais-Jarvis","year":"1986","journal-title":"Clin Endocrinol Metab"},{"key":"2020071614081458200_R30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/1523-1747.ep12580432","article-title":"Is increased 5\u03b1-reductase activity a primary phenomenon in androgen-dependent skin disorders?","volume":"89","author":"Dijkstra","year":"1987","journal-title":"J Invest Dermatol"},{"key":"2020071614081458200_R31","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1515\/JPEM.2000.13.3.253","article-title":"Increased 5\u03b1-reductase and normal 11\u03b2-hydroxysteroid dehydrogenase metabolism of C19 and C21 steroids in a young population with polycystic ovarian syndrome.","volume":"13","author":"Chin","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2020071614081458200_R32","first-page":"881","article-title":"Insulin infusion amplifies 17\u03b1-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20-lyase activity.","volume":"81","author":"Moghetti","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614081458200_R33","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0022-4731(85)90451-0","article-title":"A new defect in the peripheral conversion of cortisone to cortisol.","volume":"22","author":"Phillipou","year":"1985","journal-title":"J Steroid Biochem"},{"key":"2020071614081458200_R34","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1161\/01.HYP.33.6.1364","article-title":"Cortisol effects on body mass, blood pressure, and cholesterol in the general population.","volume":"33","author":"Fraser","year":"1999","journal-title":"Hypertension"},{"key":"2020071614081458200_R35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM199207163270304","article-title":"Detection of functional ovarian hyperandrogenism in women with androgen excess.","volume":"327","author":"Ehrmann","year":"1992","journal-title":"N Engl J Med"},{"key":"2020071614081458200_R36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0015-0282(99)00195-8","article-title":"Classification of polycystic ovary syndrome into three types according to response to human corticotropin-releasing hormone.","volume":"72","author":"Kondoh","year":"1999","journal-title":"Fertil Steril"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/88\/12\/5907\/9063244\/jcem5907.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/88\/12\/5907\/9063244\/jcem5907.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T01:29:06Z","timestamp":1594949346000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/88\/12\/5907\/2661502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12,1]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2003,12,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2003-030240","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12,1]]}}}